New drug combo shows promise for aggressive myeloma
NCT ID NCT01745640
First seen Feb 05, 2026 · Last updated May 14, 2026 · Updated 20 times
Summary
This study tested a combination of pomalidomide and dexamethasone in 63 patients with relapsed or refractory multiple myeloma who have specific high-risk genetic changes (deletion 17p or translocation 4;14). The goal was to see how well the treatment controls the disease and to check its safety. Participants received the drugs in cycles, and researchers measured how long it took for the cancer to progress.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU POITIERS-Hôpital Jean Bernard
Poitiers, 86021, France
-
CHRU RENNES 1, Hôpital Sud
Rennes, 35056, France
-
CHRU RENNES 2, Hôpital Pontchaillou
Rennes, 35033, France
-
CHRU, Hôpital A.Michallon
Grenoble, 38043, France
-
CHRU, Hôpital Purpan
Toulouse, 31059, France
-
CHRU, Hôpitaux de Brabois
Vandœuvre-lès-Nancy, 54511, France
-
CHRU, Hôtel Dieu
Nantes, 44035, France
-
CHRU- Hôpital Bretonneau
Tours, 37044, France
-
CHRU-Hôpital Sud Amiens
Amiens, 80054, France
-
CHU - Hôpital St Antoine,
Paris, 75571, France
-
CHU DIJON, Hôpital d'Enfants
Dijon, 21000, France
-
Centre Hospitalier Lyon Sud -1
Pierre-Bénite, 69495, France
-
Centre Hospitalier Lyon Sud -2
Pierre-Bénite, 69495, France
-
Centre hospitalier départemental La Roche sur Yon
La Roche-sur-Yon, 85025, France
-
Chru Caen
Caen, 14033, France
-
Chru Lille
Lille, 59037, France
-
Hôpital Haut-Leveque
Pessac, 33604, France
-
Hôpital Robert Debré, CHU Reims
Reims, 51092, France
-
Hôpital Saint-Louis
Paris, 75475, France
-
Institut Paoli Calmette,
Marseille, 13273, France
Conditions
Explore the condition pages connected to this study.